跳至主要内容
临床试验/CTRI/2018/09/015679
CTRI/2018/09/015679尚未招募未知

Comparative evaluation of combined 0.03% chloroquine phosphate with 0.1% olopatidine versus 0.1% olopatidine drops in cases of allergic keratoconjunctivitis.

FDC Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
FDC Limited

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients coming in the outpatient department with ocular itching, redness and watering and diagnosed as a case of seasonal allergic conjunctivitis on the basis of sign (hyperemia and papillaae) at slit lamp examination.

排除标准

  • 1. Uveitis, conjunctivitis (due to other cause) and other ocular pathology.
  • 2. Bronchial asthma, eczema.
  • 3. History of dry eye, blepharitis, using contact lens.
  • 4. Receiving topical or systemic medication.
  • 5. History of hypersensitivity to any constituents of the eye drops.

研究者

发起方
FDC Limited

相似试验